Your trusted destination for CME, CPD & Medical Education across the Middle East.
Octavian Therapeutics
Clarissa Sowemimo-Coker is a visionary leader in the tech and entrepreneurship fields. She is the Founder and Chief Executive Officer of Forbes Ignite, a consultancy that advises leading companies on sustainable transformation and unites global changemakers at the intersection of technology, sustainability, and social impact.
As a professor at the Parsons School of Design and the Pratt Institute, she teaches courses on financial management, business models, social innovation, and technology to the next generation of leaders. Nicole holds a BBA from the University of Hawaii, an MSc from the Parsons School of Design, and an MSc from Columbia University.
Clarissa Sowemimo-Coker is a senior biotech and life-sciences executive who served as Chief Executive Officer of Octavian Therapeutics, the rebranded name of Oxford Cannabinoid Technologies Holdings. Octavian focuses on developing pharmaceutical medicines targeting the endocannabinoid system, particularly treatments for neuropathic and visceral pain.
During her leadership, she was involved in the company's clinical development, fundraising, investor relations, strategic partnerships, and international expansion. In 2024, she represented Octavian at major industry events including HLTH Europe in Amsterdam and CPHI Middle East in Riyadh, while also attending BIO-Europe and the Jefferies Healthcare Conference.
Octavian's 2025 corporate announcement identifies her as CEO of Octavian Therapeutics and credits her with leading the company through its rebrand and fundraising strategy.
BIO MIDDLE EAST
BIO MIDDLE EAST